Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joint Corp (JYNT)
NASDAQ:JYNT
Joint (JYNT) Stock Price & Analysis
248 Followers
JYNT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.31 - $16.39
Previous Close$16.13
Volume57.97K
Average Volume (3M)93.66K
Market Cap
$241.53M
Enterprise Value$250.17M
Total Cash (Recent Filing)$16.05M
Total Debt (Recent Filing)$24.66M
Price to Earnings (P/E)-21.4
Beta1.46
Next Earnings
Aug 08, 2024EPS Estimate
-$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.75
Shares Outstanding14,973,910
10 Day Avg. Volume80,121
30 Day Avg. Volume93,664
Standard Deviation0.17
R-Squared0.26
Alpha-0.00901
Financial Highlights & Ratios
Price to Book (P/B)13.00
Price to Sales (P/S)2.37
Price to Cash Flow (P/CF)15.60
P/FCF Ratio21.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.17
Enterprise Value/Gross Profit2.72
Enterprise Value/Ebitda20.71
Forecast
1Y Price Target
$15.38Price Target Upside-3.45% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Joint News
PremiumCompany Announcements
Joint Corp Earnings Presentation and Upcoming Call
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalyst highlights the company's financial resilience as reflected by a strong balance sheet with significant cash reserves and no debt, painting a picture of financial stability.
Growth StrategyThe commitment to refranchising company-owned clinics and the partnership with a specialized investment bank is seen as a strategic move to bolster the company's growth prospects and operational efficiency.
Sales PerformanceThe company's systematic increase in franchise license sales and clinic count coupled with solid system-wide sales growth signals a robust expansion trajectory and market confidence.
Bears Say
Corporate StrategySignificant refranchising activities have not yet materialized, creating potential uncertainty for the company's future growth.
Financial PerformanceClinics opened for at least 48 months saw a decrease in system-wide comp sales by 3% year-over-year.
Operational UncertaintyThe potential sale, relocation, or closure of company-owned clinics creates additional uncertainty regarding the company's future outlook.
---
Ownership Overview
62.48% Insiders
17.67% Mutual Funds
17.77% Other Institutional Investors
2.08% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
JYNT FAQ
What was Joint Corp’s price range in the past 12 months?
Joint Corp lowest stock price was $7.31 and its highest was $16.39 in the past 12 months.
What is Joint Corp’s market cap?
Currently, no data Available
When is Joint Corp’s upcoming earnings report date?
Joint Corp’s upcoming earnings report date is Aug 08, 2024 which is in 90 days.
How were Joint Corp’s earnings last quarter?
Joint Corp released its earnings results on May 02, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.005 by $0.055.
Is Joint Corp overvalued?
According to Wall Street analysts Joint Corp’s price is currently Overvalued.
Does Joint Corp pay dividends?
Joint Corp does not currently pay dividends.
What is Joint Corp’s EPS estimate?
Joint Corp’s EPS estimate is -$0.02.
How many shares outstanding does Joint Corp have?
Joint Corp has 14,973,910 shares outstanding.
What happened to Joint Corp’s price movement after its last earnings report?
Joint Corp reported an EPS of $0.06 in its last earnings report, beating expectations of $0.005. Following the earnings report the stock price went up 25.35%.
Which hedge fund is a major shareholder of Joint Corp?
Among the largest hedge funds holding Joint Corp’s share is Bandera Partners. It holds Joint Corp’s shares valued at 38M.
---
Joint Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.38 (-3.45% Downside)
$15.38 (-3.45% Downside)
Blogger Sentiment
Bullish
JYNT Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 14.2%
Last 30 Days ▼ 14.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.75%
12-Months-Change
Fundamentals
Return on Equity
-36.22%
Trailing 12-Months
Asset Growth
-13.99%
Trailing 12-Months
Company Description
Joint Corp
The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.
---
JYNT Company Deck
---
JYNT Earnings Call
Q1 2024
0:00 / 0:00
---
JYNT Stock 12 Month Forecast
Average Price Target
$15.38
▼(-3.45% Downside)
Technical Analysis
Best Analysts Covering JYNT
1 Year
1 Year Success Rate
11/17 ratings generated profit
1 Year Average Return
+129.01%
reiterated a buy rating 4 days ago
Copying Jeff Van Sinderen's trades and holding each position for 1 Year would result in 64.71% of your transactions generating a profit, with an average return of +129.01% per trade.
---